Stable temsirolimus composition and process of preparing same
AssigneeAstron Research Limited
InventorsHarsh RAJPUT, Sandeep MEHTA, Pankaj PATEL, Bhavesh PATEL, Ashish SEHGAL, Jayanta Kumar MANDAL
Life of this patent
Estimating the term…
Abstract
The present disclosure describes a stable composition of Temsirolimus for parenteral administration. The composition includes BHA or BHT as anti-oxidants and alcoholic solvent. The pH of the composition is below 5.0. The composition also can include a chelating agent and/or a surfactant. A method of producing the composition is also described.
Claims19
A stable pharmaceutical composition of Temsirolimus for parenteral administration, comprising:
- Temsirolimus as an active pharmaceutical ingredient (API);
- at least one anti-oxidant selected from the group consisting of butylatedhydroxyanisole (BHA) and butylatedhydroxytoluene (BHT);
- and
- an alcoholic solvent,
- wherein a pH of the composition is below about 5.0.
A process for preparing a stable pharmaceutical composition of Temsirolimus for parenteral administration, comprising:
- a) preparing a solution of an anti-oxidant in a co-solvent system comprising an alcoholic solvent, the anti-oxidant being at least one selected from the group consisting of butylatedhydroxyanisole (BHA) and butylatedhydroxytoluene (BHT) and the alcoholic solvent being at least one selected from the group comprising ethanol, polyethylene glycol and propylene glycol;
- and
- b) adding Temsirolimus and optionally a chelating agent to the solution prepared in (a), the chelating agent being at least one selected from the group comprising citric acid, ascorbic acid, acetic acid and ethylenediaminetetraacetic acid (EDTA),
- wherein a pH of the solution obtained in (b) is below about 5.0.
Dependencies are inferred from the claim text.